5-624473-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018140.4(CEP72):c.406G>A(p.Asp136Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,613,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018140.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP72 | NM_018140.4 | c.406G>A | p.Asp136Asn | missense_variant, splice_region_variant | 4/12 | ENST00000264935.6 | NP_060610.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP72 | ENST00000264935.6 | c.406G>A | p.Asp136Asn | missense_variant, splice_region_variant | 4/12 | 1 | NM_018140.4 | ENSP00000264935 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251418Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135898
GnomAD4 exome AF: 0.000276 AC: 404AN: 1461198Hom.: 0 Cov.: 30 AF XY: 0.000279 AC XY: 203AN XY: 726964
GnomAD4 genome AF: 0.000210 AC: 32AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.406G>A (p.D136N) alteration is located in exon 4 (coding exon 4) of the CEP72 gene. This alteration results from a G to A substitution at nucleotide position 406, causing the aspartic acid (D) at amino acid position 136 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at